Assessment of the sedative effects of buprenorphine administered with 20 microg/kg detomidine in horses.
Authors: Love E J, Taylor P M, Murrell J, Whay H R, Waterman-Pearson A E
Journal: The Veterinary record
Summary
# Editorial Summary Optimal sedative combinations are essential for safe equine clinical procedures, yet the interaction between detomidine and buprenorphine at higher doses remained poorly characterised. Love and colleagues conducted a randomised, observer-blinded crossover trial in six horses receiving four intravenous treatments: saline controls, detomidine 10 µg/kg with buprenorphine 7.5 µg/kg, detomidine 20 µg/kg with buprenorphine 7.5 µg/kg, and detomidine 20 µg/kg with buprenorphine 10 µg/kg, with sedation assessed subjectively using visual analogue scales. Doubling the detomidine dose from 10 to 20 µg/kg significantly enhanced sedation depth when paired with 7.5 µg/kg buprenorphine, whereas increasing buprenorphine from 7.5 to 10 µg/kg alongside 20 µg/kg detomidine produced no additional sedative benefit. For practitioners, this suggests that sedation efficacy with this combination is primarily driven by detomidine dose escalation; once detomidine reaches 20 µg/kg, further buprenorphine increments offer diminishing returns, potentially allowing cost savings and reduced opioid exposure whilst maintaining adequate sedation for routine procedures.
Read the full abstract on PubMed
Practical Takeaways
- •For IV sedation in horses, detomidine dose is the primary driver of sedation depth when combined with buprenorphine; increasing buprenorphine above 7.5 µg/kg adds no additional sedative benefit with 20 µg/kg detomidine
- •Practitioners should adjust detomidine dosing (10–20 µg/kg range) to achieve desired sedation levels rather than increasing buprenorphine dose
- •This combination protocol may allow dose optimisation and cost efficiency in equine sedation protocols
Key Findings
- •Increasing detomidine dose from 10 to 20 µg/kg with fixed buprenorphine (7.5 µg/kg) significantly increased degree of sedation
- •Increasing buprenorphine dose from 7.5 to 10 µg/kg when combined with 20 µg/kg detomidine did not further increase sedation
- •Peak sedation and duration were measured using visual analogue scale assessment in a randomised, observer-blinded crossover design